by Vora Corporate Finance | Aug 19, 2025 | Insights
The BSE Sensex closed at 80,242 up by 4% and the Nifty 50 closed at 24,334 up by 3% in April 2025 amid sustained foreign fund inflows and robust corporate earnings. The market was buoyed by optimism the potential India-US trade deal and record high GST collection in...
by Vora Corporate Finance | Aug 19, 2025 | Insights
The US-China trade war has entered a new and precarious phase. What began as a series of tariffs and retaliatory measures has escalated into a systemic confrontation reshaping global trade dynamics. In early April 2025, President Trump imposed sweeping tariffs of up...
by Vora Corporate Finance | Apr 16, 2025 | Insights, Private Equity & IPO
Transaction: DCDC Kidney Care, which operates dialysis centers under the DCDC Kidney Care brand, has secured an investment of ₹150 crore from Singapore-based ABC Impact, the Asia-focused impact investor backed by Temasek. About DCDC Kidney Care: Founded in 2009, DCDC...
by Vora Corporate Finance | Apr 16, 2025 | Insights, Merger & Acquisitions
Transaction: Zydus Lifesciences Limited has entered into exclusive negotiations to purchase a controlling stake of 85.6% in France-based Amplitude Surgical SA for a deal valued at €256.8 million (over ₹2,400 crore). Zydus will file a mandatory cash tender offer for...
by Vora Corporate Finance | Apr 16, 2025 | Insights
There were No main board IPOs in March 2025 against 04 main board IPOs in February 2025. There were 07 SME IPOs in March 2025 as against 06 SME IPOs in February 2025. After heightened activity in 2024, there has been a slowdown in new listings, with no main-board...
